Original language | English |
---|---|
Pages (from-to) | 2187-2197 |
Number of pages | 11 |
Journal | Clinical Cancer Research |
Volume | 16 |
Issue number | 7 |
Publication status | Published - 2010 |
Phase I evaluation of telatinib, a vascular endothelial growth factor receptor tyrosine kinase inhibitor, in combination with irinotecan and capecitabine in patients with advanced solid tumors
M.H.G. Langenberg, P.O. Witteveen, J.M.L. Roodhart, H.M.W. Verheul, M. Mergui-Roelvink, J. van der Sar, E. Brendel, N. Laferriere, J.H.M. Schellens, E.E. Voest
Research output: Contribution to journal › Article › Academic › peer-review